Close



Apr 11, 2024 08:05AM
Apr 3, 2024 08:05AM
Apr 3, 2024 08:05AM
Feb 22, 2024 07:30AM
Feb 21, 2024 08:06AM
Feb 21, 2024 08:05AM
Feb 20, 2024 08:05AM Harmony Biosciences (HRMY) Receives U.S. Food And Drug Administration Orphan Drug Designation For Pitolisant In Prader-willi Syndrome
Feb 20, 2024 08:05AM
Jan 8, 2024 08:17AM
Jan 8, 2024 08:05AM
Dec 7, 2023 08:06AM
Dec 7, 2023 08:05AM
Dec 5, 2023 08:05AM
Oct 31, 2023 07:30AM Harmony Biosciences Reports Strong Third Quarter 2023 Financial Results
Oct 13, 2023 08:01AM
Oct 13, 2023 08:00AM
Oct 11, 2023 08:02AM
Oct 11, 2023 08:00AM
Oct 5, 2023 08:05AM
Oct 5, 2023 08:05AM
Sep 27, 2023 08:00AM HARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.
Sep 25, 2023 04:59AM
Sep 7, 2023 08:07AM
Sep 7, 2023 08:05AM
Aug 28, 2023 08:01AM
Aug 28, 2023 08:00AM
Aug 14, 2023 07:31AM
Aug 14, 2023 07:30AM HARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.
Aug 1, 2023 07:30AM
Aug 1, 2023 07:21AM
Aug 1, 2023 07:20AM
Jul 27, 2023 08:06AM
Jul 27, 2023 08:05AM
Jul 20, 2023 08:06AM
Jul 20, 2023 08:05AM HARMONY BIOSCIENCES ANNOUNCES PLANS TO INITIATE PHASE 3 REGISTRATIONAL STUDY OF PITOLISANT IN PRADER-WILLI SYNDROME FOLLOWING POSITIVE END-OF-PHASE 2 MEETING WITH THE U.S. FOOD AND DRUG ADMINISTRATION
Jun 19, 2023 09:00PM
Jun 6, 2023 08:06AM
Jun 6, 2023 08:05AM
May 25, 2023 08:05AM
May 10, 2023 08:05AM
May 2, 2023 07:30AM
May 2, 2023 07:30AM Harmony Biosciences Reports First Quarter 2023 Financial Results and Business Updates
Apr 24, 2023 08:08AM
Apr 24, 2023 08:05AM
Mar 29, 2023 08:05AM
Mar 29, 2023 08:05AM
Feb 21, 2023 07:30AM
Feb 21, 2023 07:30AM
Jan 6, 2023 04:39PM HARMONY BIOSCIENCES APPOINTS JEFFREY M. DAYNO, MD AS INTERIM CEO AND EXPANDS ROLE OF JEFF ARONIN TO EXECUTIVE CHAIRMAN
Nov 1, 2022 07:30AM

922,461 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All